stars 1 stars 2 stars 3

Labmaster Ltd develops innovative solutions for clinical and veterinary diagnostics and research. Labmaster LUCIA™ is a point-of-care immunoassay platform based on patented cathodic electrochemiluminescence (LM-CECL) technology. It enables fast, accurate and affordable human & veterinary diagnostics including human CRP, MxA, equine SAA, equine IgG kits and many more in the pipeline. We work in a positive, international work culture with determined and motivated people. Our work is driven by our strong belief in the LM-CECL technology and the possibilities it can offer to mainstream healthcare. As a fast-paced organization working hard to create quality products that meet the IVD regulatory requirements, it is ever more important that we pay attention to the positive energy at our workplace. In this effort, our work community acknowledges every team member with their unique skills and ideas. Efforts, achievements and milestones don’t go unnoticed at Labmaster.

Labmaster Ltd Questions

The Labmaster Ltd annual revenue was $4 million in 2026.

15 people are employed at Labmaster Ltd.

Labmaster Ltd is based in Kaarina, Southwest Finland.

The NAICS codes for Labmaster Ltd are [32541, 325413, 3254, 32, 325].

The SIC codes for Labmaster Ltd are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users